NextCure, Inc.
NXTC
$12.12
$0.161.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.96M | 2.81M | 3.20M | 3.73M | 3.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.76M | 8.95M | 27.29M | 11.62M | 12.46M |
| Operating Income | -9.76M | -8.95M | -27.29M | -11.62M | -12.46M |
| Income Before Tax | -9.44M | -8.62M | -26.81M | -10.98M | -11.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.44M | -8.62M | -26.81M | -10.98M | -11.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.44M | -8.62M | -26.81M | -10.98M | -11.60M |
| EBIT | -9.76M | -8.95M | -27.29M | -11.62M | -12.46M |
| EBITDA | -9.39M | -8.41M | -26.66M | -10.97M | -11.78M |
| EPS Basic | -2.37 | -3.22 | -11.29 | -4.70 | -4.97 |
| Normalized Basic EPS | -1.48 | -2.01 | -7.06 | -2.94 | -3.11 |
| EPS Diluted | -2.37 | -3.22 | -11.29 | -4.70 | -4.97 |
| Normalized Diluted EPS | -1.48 | -2.01 | -7.06 | -2.94 | -3.11 |
| Average Basic Shares Outstanding | 3.98M | 2.68M | 2.37M | 2.33M | 2.33M |
| Average Diluted Shares Outstanding | 3.98M | 2.68M | 2.37M | 2.33M | 2.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |